Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 82804-296

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 82804-296). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion-structure.jpg (Bupropion Structure)

FDA Label Image

82804-296-90 (Image 01)

82804-296-90 (Image 01)
This is a description of a medication package containing Bupropion HCI 150mg extended-release tablets. The package includes #90 XL tablets with specific identification numbers and expiration dates. The medication guide should be provided to each patient. The tablets are creamy-white to pale yellow, round, and imprinted with G784 on one side. There is a warning not to use this medication in combination with Zyban or any other medicine containing bupropion hydrochloride. The medication is manufactured by Granules India Limited and packaged by Proficient Rx LP. Storage instructions indicate keeping the medication at 25°C (77°F) and away from children's reach.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.